ABEO Abeona Therapeutics Inc.

$5.76 +3.13%

Healthcare · Pharmaceutical Preparations

Abeona Therapeutics Inc. (ABEO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $329 million. Shares last traded at $5.76, 23.4% below their 52-week high. Over the past year the stock is down 3.9%. Net profit margin is -1223.1%, below the peer median of -0.1%. Revenue grew 66.3% year over year.

Market Cap

$329M

Shares Out

57.0M

EPS (TTM)

$2.28

P/E Ratio

2.53

P/S Ratio

56.46

P/B Ratio

2.27

Dividend / Share

—

Dividend Yield

—

52-Week High

$7.53

52-Week Low

$4.00

Volume

65,565

Avg Vol (3m)

74,819.603

Performance

+4.06%

+12.27%

+26.43%

+15.18%

YTD

+8.36%

-3.92%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

56.69

SMA (50)

$5.53

SMA (200)

$5.24

Price vs SMA50

+4.16%

Price vs SMA200

+10.00%

ATR (14)

$0.23

Financials

Revenue

$6M

Net Income

$-71M

Gross Margin

—

Operating Margin

-1536.9%

Net Margin

-1223.1%

Return on Equity

-49.1%

Return on Assets

-35.9%

Current Ratio

5.89

Debt / Equity

0.12

Revenue Growth (YoY)

+66.3%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.30	2026-05-13
FY 2025	$1.01	2026-03-17
Q3 2025	$1.35	2025-11-12
Q2 2025	$1.47	2025-08-14
Q1 2026	$-0.24	2026-05-13
FY 2025	$-1.55	2026-03-17

Full earnings history →

Pharmaceutical Preparations peers

ABEO vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

56.46 / 3.54 med

+1496% premium

Net margin vs peers

-1223.1% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.